
|Articles|April 1, 2007
Troubles with topicals
National report - Dermatologists and other trained medical professionals should oversee use of topical numbing creams, and should use only low concentrations for only short periods of time to ensure the safety of patients, say experts in the field and officials from the Food and Drug Administration (FDA).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
4
World Cancer Day 2026: La Roche-Posay and ONS Partner to Launch Skin of Color Toxicity Repository
5











